This Antiphospholipid Syndrome Patient Felt Relief When the FDA Approved COVID Boosters
source: pixabay.com

This Antiphospholipid Syndrome Patient Felt Relief When the FDA Approved COVID Boosters

According to a story from Ebene Magazine, the US Food and Drug Administration (FDA) officially authorized that immunocompromised people could receive a third booster shot of the COVID-19 vaccine. This…

Continue Reading This Antiphospholipid Syndrome Patient Felt Relief When the FDA Approved COVID Boosters

Atezolizumab and Bevacizumab Improves Survival With Unresectable Hepatocellular Carcinoma

New treatments for unresectable hepatocellular carcinoma (HCC) were approved based on a Phase 3 clinical trial. Richard Kim has recently provided an overview of this study. The Study This study ultimately…

Continue Reading Atezolizumab and Bevacizumab Improves Survival With Unresectable Hepatocellular Carcinoma